{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T12:30:00Z","timestamp":1789734600022,"version":"4.0.1"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T00:00:00Z","timestamp":1771459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T00:00:00Z","timestamp":1771459200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Am J Cardiovasc Drugs"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1007\/s40256-026-00789-6","type":"journal-article","created":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T16:27:15Z","timestamp":1771518435000},"page":"345-358","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Beta-Blockers After Myocardial Infarction Without Reduced Ejection Fraction: A Meta-Analysis of Kaplan\u2013Meier Reconstructed Individual Patient Data"],"prefix":"10.1007","volume":"26","author":[{"given":"Ameer","family":"Awashra","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-2718-8627","authenticated-orcid":false,"given":"Ahmed","family":"Emara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed Mazen","family":"Amin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed W.","family":"Hageen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed S.","family":"Elgendy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed Saad","family":"Rakab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khadeeja Ali","family":"Hamzah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdullah Faisal","family":"Albukhari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abubakar","family":"Nazir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdalhakim","family":"Shubietah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anan Abu","family":"Rmilah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed","family":"Ruzieh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,19]]},"reference":[{"issue":"14","key":"789_CR1","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1056\/NEJMoa2404204","volume":"391","author":"J Silvain","year":"2024","unstructured":"Silvain J, Cayla G, Ferrari E, Range G, Puymirat E, Delarche N, et al. Beta-blocker interruption or continuation after myocardial infarction. N Engl J Med. 2024;391(14):1277\u201386.","journal-title":"N Engl J Med"},{"issue":"15","key":"789_CR2","doi-asserted-by":"publisher","first-page":"1372","DOI":"10.1056\/NEJMoa2401479","volume":"390","author":"T Yndigegn","year":"2024","unstructured":"Yndigegn T, Lindahl B, Mars K, Alfredsson J, Benatar J, Brandin L, et al. Beta-blockers after myocardial infarction and preserved ejection fraction. N Engl J Med. 2024;390(15):1372\u201381.","journal-title":"N Engl J Med"},{"key":"789_CR3","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000001309","author":"SV Rao","year":"2025","unstructured":"Rao SV, O\u2019Donoghue ML, Ruel M, Rab T, Tamis-Holland JE, Alexander JH, et al. ACC\/AHA\/ACEP\/NAEMSP\/SCAI Guideline for the Management of Patients with Acute Coronary Syndromes: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation [Internet]. 2025. https:\/\/doi.org\/10.1161\/CIR.0000000000001309.","journal-title":"Circulation [Internet]."},{"issue":"9","key":"789_CR4","doi-asserted-by":"publisher","first-page":"e9","DOI":"10.1161\/CIR.0000000000001168","volume":"148","author":"SS Virani","year":"2023","unstructured":"Virani SS, Newby LK, Arnold SV, Bittner V, Brewer LC, Demeter SH, et al. 2023 AHA\/ACC\/ACCP\/ASPC\/NLA\/PCNA Guideline for the Management of Patients with Chronic Coronary Disease: a report of the American Heart Association\/American College of Cardiology Joint Committee on Clinical Practice Guidelines. Circulation. 2023;148(9):e9-119.","journal-title":"Circulation"},{"issue":"38","key":"789_CR5","doi-asserted-by":"publisher","first-page":"3720","DOI":"10.1093\/eurheartj\/ehad191","volume":"44","author":"RA Byrne","year":"2023","unstructured":"Byrne RA, Rossello X, Coughlan JJ, Barbato E, Berry C, Chieffo A, et al. 2023 ESC Guidelines for the management of acute coronary syndromes: developed by the Task Force on the Management of Acute Coronary Syndromes of the European Society of Cardiology (ESC). Eur Heart J. 2023;44(38):3720\u2013826.","journal-title":"Eur Heart J"},{"issue":"36","key":"789_CR6","doi-asserted-by":"publisher","first-page":"3415","DOI":"10.1093\/eurheartj\/ehae177","volume":"45","author":"C Vrints","year":"2024","unstructured":"Vrints C, Andreotti F, Koskinas KC, Rossello X, Adamo M, Ainslie J, et al. 2024 ESC Guidelines for the management of chronic coronary syndromes. Eur Heart J. 2024;45(36):3415\u2013537.","journal-title":"Eur Heart J"},{"key":"789_CR7","doi-asserted-by":"publisher","first-page":"1889","DOI":"10.1056\/NEJMoa2504735","volume":"393","author":"B Ibanez","year":"2025","unstructured":"Ibanez B, Latini R, Rossello X, Dominguez-Rodriguez A, Fern\u00e1ndez-Vazquez F, Pelizzoni V, et al. Beta-blockers after myocardial infarction without reduced ejection fraction. N Engl J Med. 2025;393:1889\u2013990.","journal-title":"N Engl J Med"},{"key":"789_CR8","doi-asserted-by":"publisher","first-page":"1901","DOI":"10.1056\/NEJMoa2505985","volume":"393","author":"J Munkhaugen","year":"2025","unstructured":"Munkhaugen J, Kristensen AMD, Halvorsen S, Holmager T, Olsen MH, Bakken A, et al. Beta-blockers after myocardial infarction in patients without heart failure. N Engl J Med. 2025;393:1901\u201311.","journal-title":"N Engl J Med"},{"issue":"1","key":"789_CR9","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1186\/s13643-021-01626-4","volume":"10","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. Syst Rev. 2021;10(1):89.","journal-title":"Syst Rev"},{"key":"789_CR10","unstructured":"Cochrane Handbook for Systematic Reviews of Interventions | Cochrane [Internet]. https:\/\/www.cochrane.org\/authors\/handbooks-and-manuals\/handbook. Accessed 23 Oct 2025."},{"issue":"1","key":"789_CR11","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1186\/s13643-016-0384-4","volume":"5","author":"M Ouzzani","year":"2016","unstructured":"Ouzzani M, Hammady H, Fedorowicz Z, Elmagarmid A. Rayyan-A web and mobile app for systematic reviews. Syst Rev. 2016;5(1):210.","journal-title":"Syst Rev"},{"issue":"366","key":"789_CR12","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.l4898","volume":"28","author":"JAC Sterne","year":"2019","unstructured":"Sterne JAC, Savovi\u0107 J, Page MJ, Elbers RG, Blencowe NS, Boutron I, et al. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ. 2019;28(366):l4898.","journal-title":"BMJ"},{"issue":"7650","key":"789_CR13","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","volume":"336","author":"GH Guyatt","year":"2008","unstructured":"Guyatt GH, Oxman AD, Vist GE, Kunz R, Falck-Ytter Y, Alonso-Coello P, et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ. 2008;336(7650):924\u20136.","journal-title":"BMJ"},{"issue":"4","key":"789_CR14","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1136\/ebmental-2019-300117","volume":"22","author":"S Balduzzi","year":"2019","unstructured":"Balduzzi S, R\u00fccker G, Schwarzer G. How to perform a meta-analysis with R: a practical tutorial. Evid Based Ment Health. 2019;22(4):153\u201360.","journal-title":"Evid Based Ment Health"},{"issue":"1","key":"789_CR15","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1186\/s12874-021-01308-8","volume":"21","author":"N Liu","year":"2021","unstructured":"Liu N, Zhou Y, Lee JJ. IPDfromKM: reconstruct individual patient data from published Kaplan\u2013Meier survival curves. BMC Med Res Methodol. 2021;21(1):111.","journal-title":"BMC Med Res Methodol"},{"issue":"4","key":"789_CR16","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1177\/1536867X1801700402","volume":"17","author":"Y Wei","year":"2017","unstructured":"Wei Y, Royston P. Reconstructing time-to-event data from published Kaplan\u2013Meier curves. Stata J Promot Commun Stat Stata. 2017;17(4):786\u2013802.","journal-title":"Stata J Promot Commun Stat Stata"},{"issue":"3","key":"789_CR17","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1093\/biomet\/81.3.515","volume":"81","author":"PM Grambsch","year":"1994","unstructured":"Grambsch PM, Therneau TM. Proportional hazards tests and diagnostics based on weighted residuals. Biometrika. 1994;81(3):515\u201326.","journal-title":"Biometrika"},{"issue":"1","key":"789_CR18","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s12874-017-0315-7","volume":"17","author":"J Wetterslev","year":"2017","unstructured":"Wetterslev J, Jakobsen JC, Gluud C. Trial sequential analysis in systematic reviews with meta-analysis. BMC Med Res Methodol. 2017;17(1):39.","journal-title":"BMC Med Res Methodol"},{"issue":"8","key":"789_CR19","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1016\/j.jclinepi.2007.10.007","volume":"61","author":"J Brok","year":"2008","unstructured":"Brok J, Thorlund K, Gluud C, Wetterslev J. Trial sequential analysis reveals insufficient information size and potentially false positive results in many meta-analyses. J Clin Epidemiol. 2008;61(8):763\u20139.","journal-title":"J Clin Epidemiol"},{"issue":"199","key":"789_CR20","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.amjcard.2023.04.042","volume":"15","author":"M Amano","year":"2023","unstructured":"Amano M, Izumi C, Watanabe H, Ozasa N, Morimoto T, Bingyuan B, et al. Effects of long-term carvedilol therapy in patients with ST-segment elevation myocardial infarction and mildly reduced left ventricular ejection fraction. Am J Cardiol. 2023;15(199):50\u20138.","journal-title":"Am J Cardiol"},{"issue":"2","key":"789_CR21","doi-asserted-by":"publisher","first-page":"398","DOI":"10.21037\/cdt-24-368","volume":"15","author":"RAF Gomes","year":"2025","unstructured":"Gomes RAF, Furtado LCC, Montenegro MV, Filho DCS. Beta-blockers in post-myocardial infarction with preserved ejection fraction: systematic review and meta-analysis. Cardiovasc Diagn Ther. 2025;15(2):398\u2013413.","journal-title":"Cardiovasc Diagn Ther."},{"issue":"3","key":"789_CR22","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1093\/ehjcvp\/pvad093","volume":"10","author":"AMD Kristensen","year":"2024","unstructured":"Kristensen AMD, Munkhaugen J, Halvorsen S, Olsen MH, Bakken A, Sehested TSG, et al. The Danish-Norwegian randomized trial on beta-blocker therapy after myocardial infarction: design, rationale, and baseline characteristics. Eur Heart J Cardiovasc Pharmacother. 2024;10(3):175\u201383.","journal-title":"Eur Heart J Cardiovasc Pharmacother."},{"issue":"27","key":"789_CR23","doi-asserted-by":"publisher","first-page":"2549","DOI":"10.1093\/eurheartj\/ehac223","volume":"43","author":"S Frantz","year":"2022","unstructured":"Frantz S, Hundertmark MJ, Schulz-Menger J, Bengel FM, Bauersachs J. Left ventricular remodelling post-myocardial infarction: pathophysiology, imaging, and novel therapies. Eur Heart J. 2022;43(27):2549\u201361.","journal-title":"Eur Heart J"},{"issue":"20","key":"789_CR24","doi-asserted-by":"publisher","DOI":"10.3390\/ijms242015472","volume":"24","author":"AA Manolis","year":"2023","unstructured":"Manolis AA, Manolis TA, Manolis AS. Neurohumoral activation in heart failure. Int J Mol Sci. 2023;24(20):15472.","journal-title":"Int J Mol Sci"},{"issue":"8","key":"789_CR25","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.3390\/life12081111","volume":"12","author":"SA Leanc\u0103","year":"2022","unstructured":"Leanc\u0103 SA, Cri\u0219u D, Petri\u0219 AO, Afr\u0103s\u00e2nie I, Genes A, Costache AD, et al. Left ventricular remodeling after myocardial infarction: from physiopathology to treatment. Life. 2022;12(8):1111.","journal-title":"Life"},{"key":"789_CR26","doi-asserted-by":"crossref","unstructured":"Awashra A, AbuBaha M, Emara A, Hamdan A, Zahran A, Ibrahem M, et al. Reassessing PCI timing in high bleeding risk patients: evidence, strategies, and outcomes. Cathet Cardio Intervent. 2025;ccd.70410.","DOI":"10.1002\/ccd.70410"},{"key":"789_CR27","doi-asserted-by":"crossref","unstructured":"Rossello X, Dominguez-Rodriguez A, Latini R, S\u00e1nchez PL, Raposeiras-Roub\u00edn S, Anguita M, et al. Beta-blockers after myocardial infarction: effects according to sex in the REBOOT trial. Eur Heart J. 2025;ehaf673.","DOI":"10.1093\/eurheartj\/ehaf673"}],"container-title":["American Journal of Cardiovascular Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40256-026-00789-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40256-026-00789-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40256-026-00789-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T11:36:42Z","timestamp":1776857802000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40256-026-00789-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,19]]},"references-count":27,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["789"],"URL":"https:\/\/doi.org\/10.1007\/s40256-026-00789-6","relation":{},"ISSN":["1175-3277","1179-187X"],"issn-type":[{"value":"1175-3277","type":"print"},{"value":"1179-187X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,19]]},"assertion":[{"value":"8 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All required data are included in the manuscript or the Supplementary Material. Any additional data can be obtained from the corresponding author upon reasonable request.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Data Availability"}},{"value":"A.A. and A.E: validation, conceptualization, material preparation, methodology, and writing\u2014original draft. A.M.A.: data curation, formal analysis, and writing\u2014original draft. A.W.H.: methodology and writing\u2014original draft. M.S.E., M.S.R., K.A.H., A.F.A., and A.N.: methodology, investigation, and writing\u2014original draft. A.S., A.R., and M.R.: conceptualization, supervision, and writing\u2014review and editing. No paper mills or generative artificial intelligence (AI) were used. All authors read and approved the final manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Author Contributions"}},{"value":"Ameer Awashra, Ahmed Emara, Ahmed Mazen Amin, Ahmed W. Hageen, Mohamed S. Elgendy, Mohamed Saad Rakab, Khadeeja Ali Hamzah, Abdullah Faisal Albukhari, Abubakar Nazir, Abdalhakim Shubietah, Anan Abu Rmilah, and Mohammed Ruzieh declare that they have no potential conflicts of interest relevant to the contents of this manuscript.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}},{"value":"Not applicable.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical trial number"}}]}}